Robust transcriptional signatures for low-input RNA samples based on relative expression orderings

Huaping Liu, Yawei Li, Jun He, +9

BMC Genomics

Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms

Qingzhou Guan, Rou Chen, Haidan Yan, +9

Oncotarget

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection

Lu Ao, Xuekun Song, Xiangyü Li, +9

Oncotarget

Surgical OncologyMulti-omics DistinctionPrognosisPathologyHcc Patients +19

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings

Lu Ao, Zimei Zhang, Qingzhou Guan, +8

Liver International

Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites

Jun Cheng, You Guo, Qiao Gao, +8

Oncotarget

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer

Qingzhou Guan, Haidan Yan, Yanhua Chen, +10

BMC Genomics

Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells

Yutong Shen, Mengying Tong, Qirui Liang, +6

The Pharmacogenomics Journal

A rank-based algorithm of differential expression analysis for small cell line data with statistical control

Xiangyü Li, Hao Cai, Xianlong Wang, +8

Briefings in Bioinformatics

EngineeringGene Expression ProfilingTrajectory AnalysisDifferential Expression AnalysisData Science +18

Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood

Hongdong Li, Zheng Guo, You Guo, +5

Oncotarget

Methylation DifferencesAd BiomarkersNeurodegenerative DiseasesAlzheimer's DiseaseAging +13

Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post- chemotherapy tissues

Mengsha Tong, Weicheng Zheng, Xingrong Lu, +9

Oncotarget